Imperial College London

ProfessorBobBrown

Faculty of MedicineDepartment of Surgery & Cancer

Senior Research Investigator
 
 
 
//

Contact

 

+44 (0)20 7594 1804b.brown Website

 
 
//

Assistant

 

Ms Sophie Lions +44 (0)20 7594 2792

 
//

Location

 

1 007Institute of Reproductive and Developmental BiologyHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Tutt:2017:10.1158/1538-7445.SABCS16-S6-01,
author = {Tutt, A and Cheang, MCU and Kilburn, L and Tovey, H and Gillett, C and Pinder, S and Lanchbury, J and Abraham, J and Barrett, S and Barrett-Lee, P and Chan, S and Gazinska, P and Grigoriadis, A and Kernaghan, S and Hoadley, K and Gutin, A and Harper-Wynne, C and Hatton, M and Owen, J and Parker, P and Roylance, R and Shaw, A and Smith, I and Thompson, R and Timms, K and Wardley, A and Wilson, G and Harries, M and Ellis, P and Ashworth, A and Perou, C and Bliss, J and Rahman, N and Brown, R},
doi = {10.1158/1538-7445.SABCS16-S6-01},
publisher = {AMER ASSOC CANCER RESEARCH},
title = {BRCA1 methylation status, silencing and treatment effect in the TNT trial: A randomized phase III trial of carboplatin compared with docetaxel for patients with metastatic or recurrent locally advanced triple negative or BRCA1/2 breast cancer (CRUK/07/012)},
url = {http://dx.doi.org/10.1158/1538-7445.SABCS16-S6-01},
year = {2017}
}

RIS format (EndNote, RefMan)

TY  - CPAPER
AU - Tutt,A
AU - Cheang,MCU
AU - Kilburn,L
AU - Tovey,H
AU - Gillett,C
AU - Pinder,S
AU - Lanchbury,J
AU - Abraham,J
AU - Barrett,S
AU - Barrett-Lee,P
AU - Chan,S
AU - Gazinska,P
AU - Grigoriadis,A
AU - Kernaghan,S
AU - Hoadley,K
AU - Gutin,A
AU - Harper-Wynne,C
AU - Hatton,M
AU - Owen,J
AU - Parker,P
AU - Roylance,R
AU - Shaw,A
AU - Smith,I
AU - Thompson,R
AU - Timms,K
AU - Wardley,A
AU - Wilson,G
AU - Harries,M
AU - Ellis,P
AU - Ashworth,A
AU - Perou,C
AU - Bliss,J
AU - Rahman,N
AU - Brown,R
DO - 10.1158/1538-7445.SABCS16-S6-01
PB - AMER ASSOC CANCER RESEARCH
PY - 2017///
SN - 0008-5472
TI - BRCA1 methylation status, silencing and treatment effect in the TNT trial: A randomized phase III trial of carboplatin compared with docetaxel for patients with metastatic or recurrent locally advanced triple negative or BRCA1/2 breast cancer (CRUK/07/012)
UR - http://dx.doi.org/10.1158/1538-7445.SABCS16-S6-01
UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000397999003034&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
ER -